LONA
LONA
NASDAQ · Pharmaceuticals

Leonabio Inc

$4.43
-0.14 (-2.96%)
As of Nov 7, 2:39 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +807.9% upside
Low Target $30.63
Average Target $40.22
High Target $46.08
Current Price $4.43
Current
$4.43
Target
$40.22
$30.63 $40.22 avg $46.08
Scenario Analysis
Bear Case
$30.63
591.4%
Low target
Base Case
$40.22
+807.9%
Avg target
Bull Case
$46.08
+940.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$14.21
-68.8% from high
52-Week Low
$2.21
+100.5% from low
Target vs 52W High
$40.22
+183.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%